WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Scott K. Murano
Partner
Corporate
Palo Alto
San Francisco
smurano@wsgr.com

D650-849-3316

Download vCard
LinkedIn
Open PDF
  • Comprehensive Corporate Experience

    Scott advises life sciences and technology companies on corporate matters, including formation and operation, corporate governance, IP and licensing, and employment-related matters.

  • Recognized by Peer Practitioners

    Scott has been recognized in legal industry rankings, based on surveys of peer legal practitioners.

Scott Murano is a corporate and securities partner in Wilson Sonsini Goodrich & Rosati's Palo Alto and San Francisco offices. Scott advises companies on general corporate matters, including formation and operation, corporate governance, intellectual property and licensing, and employment-related matters. He also has assisted companies in numerous capital raising transactions, including early- and later-stage venture capital financings, debt financings, and public offerings. In addition, Scott advises companies on transactional matters and has worked on a number of merger and acquisition transactions, including public and private company mergers and acquisitions and joint ventures. Scott's experience with venture capital financings and public offerings includes representation of venture capital firms.

Experience

Scott Murano is a corporate and securities partner in Wilson Sonsini Goodrich & Rosati's Palo Alto and San Francisco offices. Scott advises companies on general corporate matters, including formation and operation, corporate governance, intellectual property and licensing, and employment-related matters. He also has assisted companies in numerous capital raising transactions, including early- and later-stage venture capital financings, debt financings, and public offerings. In addition, Scott advises companies on transactional matters and has worked on a number of merger and acquisition transactions, including public and private company mergers and acquisitions and joint ventures. Scott's experience with venture capital financings and public offerings includes representation of venture capital firms.

Education
  • J.D., Northwestern Pritzker School of Law, 2001Editor, Journal of International Law and Business
  • B.S., Haas School of Business, University of California, Berkeley, 1996With Honors
Associations and Memberships
  • American Bar Association
  • San Francisco Bar Association
Honors
  • Named to the 2014 edition of the "Rising Stars" list published by Northern California Super Lawyers
Admissions
  • State Bar of California
Credentials
Education
  • J.D., Northwestern Pritzker School of Law, 2001Editor, Journal of International Law and Business
  • B.S., Haas School of Business, University of California, Berkeley, 1996With Honors
Associations and Memberships
  • American Bar Association
  • San Francisco Bar Association
Honors
  • Named to the 2014 edition of the "Rising Stars" list published by Northern California Super Lawyers
Admissions
  • State Bar of California
Focus Areas
  • Corporate
  • Corporate Life Sciences
  • Digital Health
  • Emerging Companies and Venture Capital
  • Life Sciences
  • Medical Devices
  • Mergers & Acquisitions
Recent Insights
Client Highlights
Wilson Sonsini Advises Nervonik on $52.5 Million Series B Financing
On April 27, 2026, Nervonik, a clinical-stage medical device company developing next-generation peripheral nerve stimulation (PNS) technologies, announced the closing of an oversubscribed $52.5 million Series B financing. The round was led by Amzak Health, with participation from Elevage Medical Technologies, U.S. Venture Partners (USVP), Lumira Ventures, Foothill Ventures, and Shangbay Capital. The proceeds from the financing will support the continued development and commercialization of Nervonik's PNS system, including further development of its proprietary sensing capabilities. Wilson Sonsini Goodrich & Rosati advised Nervonik on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Bolt Medical on Merger with Boston Scientific
On January 8, 2025, Boston Scientific announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for the treatment of coronary and peripheral artery disease, for up to $900 million. Wilson Sonsini Goodrich & Rosati advised Bolt Medical on the transaction.
Learn More
View All
Recent Events
Affiliated Programs
American Diabetes Association HealthTech Showcase
Wilson Sonsini is proud to support the American Diabetes Association' 2023 Silicon Valley Leaders Forum HealthTech Showcase as the Innovation Catalyst sponsor.
Learn More
WSGR Events
Phoenix 2020: Medical Device and Diagnostic Conference
As the organizers of the Phoenix Conference, we take a great deal of pride in our annual event, which has long provided medical device and diagnostic executives with an unrivaled experience that helps to inform and shape company strategy for the years ahead.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.